Transcat (TRNS) Receives Daily Media Impact Rating of 0.13

News stories about Transcat (NASDAQ:TRNS) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Transcat earned a daily sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the scientific and technical instruments company an impact score of 46.8071870751371 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Shares of Transcat traded up $0.45, reaching $20.55, on Monday, Marketbeat.com reports. 107 shares of the company were exchanged, compared to its average volume of 41,820. The firm has a market capitalization of $144.67 million, a PE ratio of 28.94, a price-to-earnings-growth ratio of 2.70 and a beta of 0.42. Transcat has a fifty-two week low of $11.80 and a fifty-two week high of $21.10. The company has a quick ratio of 1.32, a current ratio of 1.92 and a debt-to-equity ratio of 0.40.

Transcat (NASDAQ:TRNS) last announced its quarterly earnings results on Wednesday, May 23rd. The scientific and technical instruments company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.04. The business had revenue of $42.45 million for the quarter, compared to analyst estimates of $40.70 million. Transcat had a net margin of 3.82% and a return on equity of 10.83%. analysts expect that Transcat will post 0.93 EPS for the current year.

A number of research firms have recently commented on TRNS. Zacks Investment Research raised Transcat from a “hold” rating to a “buy” rating and set a $20.00 price objective on the stock in a research note on Saturday, May 26th. ValuEngine raised Transcat from a “hold” rating to a “buy” rating in a research note on Wednesday, April 11th. Five investment analysts have rated the stock with a buy rating, Transcat currently has a consensus rating of “Buy” and an average target price of $20.50.

In other Transcat news, Director Alan H. Resnick sold 1,916 shares of the firm’s stock in a transaction on Friday, June 8th. The shares were sold at an average price of $19.79, for a total value of $37,917.64. Following the sale, the director now owns 35,400 shares of the company’s stock, valued at approximately $700,566. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Chairman Charles P. Hadeed sold 17,700 shares of the firm’s stock in a transaction on Wednesday, May 30th. The stock was sold at an average price of $18.18, for a total transaction of $321,786.00. Following the completion of the sale, the chairman now directly owns 77,474 shares in the company, valued at approximately $1,408,477.32. The disclosure for this sale can be found here. 8.80% of the stock is owned by company insiders.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services.

Insider Buying and Selling by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply